Literature DB >> 30685648

Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.

Wojciech Łopuszyński1, Marek Szczubiał2, Yolanda Millán3, Silvia Guil-Luna3, Raquel Sánchez-Céspedes3, Juana Martin de Las Mulas3, Anna Śmiech4, Kamila Bulak4.   

Abstract

The aim of this study was to compare the expression of p63 protein and calponin in terms of their affinity and specificity for myoepithelial cells in canine mammary tumours. The studied material included 10 benign and 32 malignant mammary tumours from female dogs treated with mastectomy. Primary mouse monoclonal antibodies directed against p63 protein clone 4A4 and calponin clone CALP were used in single- and doublestain system of immunohistochemical reaction. The investigations have shown that majority of myoepithelial cells in benign tumours and carcinomas in situ exhibited strong positive labelling for both markers. In other malignant tumours strong immunoreactivity was observed in resting myoepithelial cells (MECs) and hypertrophic myoepithelial cells (HMECs), while the immunoreactivity in spindle-stellate myoepithelial cells (SMECs) and rounded myoepithelial cells (RMECs) was moderate. The granular-diffuse nuclear expression of p63 protein was observed only in myoepithelial cells. In terms of calponin, diffuse cytoplasmic expression was noted not only in myoepithelial cell but also in some stromal fibroblasts and vascular smooth muscle cells. The epithelial cells did not exhibit specific expression of the investigated markers. The obtained results indicate that p63 is a sensitive and more specific marker of myoepithelial cells in canine mammary tumours compared with calponin. These findings suggest that the immunohistochemical analysis peformed with the use of p63 can be a valuable complement of routine histological examinations of canine mammary tumours facilitating identification of tumours with myoepithelial component.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calponin; Female dogs; Immunohistochemistry; Mammary tumours; p63 protein

Mesh:

Substances:

Year:  2019        PMID: 30685648     DOI: 10.1016/j.rvsc.2019.01.017

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  3 in total

1.  Mammary Fibroadenoma in Cats: A Matter of Classification.

Authors:  Filippo Torrigiani; Valentina Moccia; Barbara Brunetti; Francesca Millanta; Guillermo Valdivia; Laura Peña; Laura Cavicchioli; Valentina Zappulli
Journal:  Vet Sci       Date:  2022-05-26

2.  Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma.

Authors:  R Sánchez-Céspedes; M D Fernández-Martínez; A I Raya; C Pineda; I López; Y Millán
Journal:  BMC Vet Res       Date:  2021-05-25       Impact factor: 2.741

3.  Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas.

Authors:  Florian Chocteau; Jérôme Abadie; Delphine Loussouarn; Frédérique Nguyen
Journal:  Front Vet Sci       Date:  2019-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.